Genkyotex logo — company profile

Genkyotex

Founded 2006 2-10 employees Post-IPO Equity Total: $85.35M Biotechnology, Health Care +1

General Information

Company Name Genkyotex
Founded Year 2006
Employees 2-10
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Genkyotex. To contact Genkyotex, visit genkyotex.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Genkyotex compare?

A PDF of Genkyotex and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Genkyotex soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Genkyotex

Genkyotex is a biotechnology company founded in 2006 with a focus on developing innovative medications that inhibit enzymes responsible for producing oxygen radicals. The company's advanced drugs aim to treat acute and chronic conditions mediated by oxygen radicals with enhanced specificity, safety, and efficacy compared to current antioxidant therapies, providing a notable competitive edge. Genkyotex initially applies its technology to cardiovascular, metabolic, and neurodegenerative diseases. The company received a €4.90M Post-IPO Equity investment on 06 February 2020.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity €4.90M -
06 Feb 2020
Post IPO Equity €7.50M -
21 Aug 2018
Post IPO Equity Fr.20.00M 7
VI Partners, Andera Partner +5
07 Jan 2015
Series C Fr.25.00M 4
Andera Partner, MP Healthcare Venture Management +2
09 Jul 2012
Series C $20.40M 5
Andera Partner, MP Healthcare Venture Management +3
24 May 2011
Series A Fr.2.00M -
15 May 2009
Series A $4.00M 1
Societe Generale Asset Management
05 May 2008
Seed Round $1.55M 1
Eclosion SA
30 Jan 2006

Genkyotex Alternatives & Competitors

Genkyotex vs

Rare Science. Rare Compassion. Rare Solutions.

11 employees
Biotechnology, Pharmaceutical

FAQ About Genkyotex

Genkyotex is focused on developing innovative medications that inhibit enzymes responsible for producing oxygen radicals. These advanced drugs aim to treat both acute and chronic conditions mediated by oxygen radicals with enhanced specificity, safety, and efficacy compared to current antioxidant th...
Genkyotex was founded in 2006.
Genkyotex operates in Biotechnology, Health Care and Pharmaceutical.
Genkyotex has approximately 2-10 employees.
Genkyotex has completed 8 funding rounds, raising a total of $85.35M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Genkyotex include Cornerstone Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Genkyotex and Cornerstone Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Genkyotex, https://bouncewatch.com/company/genkyotex, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes